Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
GV, Sanofi drive British biotech OMass to $100M series B, fueling work on undruggable targets
Fierce Biotech
Thu, 04/28/22 - 11:07 am
Google Ventures
Northpond Ventures
Sanofi
Sanofi Ventures
funding
OMass Therapeutics
Sanofi taps McLaren to apply racing know-how to pharma manufacturing
Fierce Pharma
Tue, 04/26/22 - 10:46 am
Sanofi
drug manufacturing
McLaren
digital imaging
Works gets underway on new Sanofi vaccine facility in Singapore
Biopharma Reporter
Sat, 04/23/22 - 03:53 pm
Sanofi
vaccines
Singapore
Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran
BioSpace
Thu, 04/21/22 - 11:27 pm
Sanofi
Terran Biosciences
CNS
psychedelic drugs
Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets
BioSpace
Thu, 04/21/22 - 10:54 am
Terran Biosciences
Sanofi
CNS
Sanofi's latest analysis of Rezurock can inform future research, company says
Fierce Pharma
Thu, 04/21/22 - 10:34 am
Sanofi
Kadmon
M&A
graft vs host disease
Rezurock
The mysterious case of Viatris and the missing insulin label deepens
Fierce Pharma
Wed, 04/13/22 - 10:42 am
Viatris
insulin
diabetes
biosimilars
Sanofi
Lantus
product recalls
Could This Drug Candidate Be a Blockbuster for Sanofi?
Motley Fool
Sun, 04/10/22 - 07:43 pm
Sanofi
efanesoctocog alfa
hemophilia A
Sanofi cuts 2 dozen Kadmon staffers after $1.9B buyout: filing
Fierce Pharma
Wed, 04/6/22 - 12:26 pm
Sanofi
Kadmon
layoffs
ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late
EP Vantage
Tue, 04/5/22 - 10:59 am
AstraZeneca
Ionis Pharmaceuticals
AZD8233
cholesterol
ACC
Amgen
Sanofi
Novartis
Regeneron
FDA accepts Regeneron, Sanofi’s Dupixent for priority review
Pharmaceutical Business Review
Tue, 04/5/22 - 10:53 am
Regeneron
Sanofi
Dupixent
FDA
eosinophilic esophagitis
Sanofi launches DE&I board with outside advisors, the first of its kind in pharma
Fierce Pharma
Mon, 04/4/22 - 10:55 am
Sanofi
diversity
inclusion
Sanofi's CDMO spinoff set for next month as new group targets 2022 revenues of €1B
Fierce Pharma
Fri, 04/1/22 - 10:32 am
Sanofi
spinoffs
Europe
API
CDMO
EuroAPI
Sanofi in the News: Grand Expectations and Paul Hudson's $12.3M Salary
BioSpace
Thu, 03/31/22 - 11:26 pm
Sanofi
Paul Hudson
Pharma CEOs
IGM Biosciences
executive pay
Sanofi Commits Potential $6B to IGM (Antibodies) in New Collab
BioSpace
Tue, 03/29/22 - 10:53 am
Sanofi
IGM Biosciences
oncology
immunology
antibodies
drug discovery
cancer
Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Roche
tiragolumab
Giredestrant
Sanofi
Eli Lilly
tirzepatide
Novo Nordisk
GSK
Pfizer
RSV
Sanofi's Xenpozyme gets approval in Japan for rare genetic disease
Seeking Alpha
Mon, 03/28/22 - 10:30 am
Sanofi
Xenpozyme
Japan
ASMD
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Eli Lilly
lebrikizumab
Demira
Sanofi
Regeneron
Dupixent
atopic dermatitis
Synthetic Antibodies to be Designed with Organoids
Science & Enterprise
Tue, 03/22/22 - 11:13 pm
antibodies
synthetic antibodies
organoids
Prellis Biologics
Sanofi
Sanofi preps API spinoff for Paris exchange listing, shareholders reap dividend
Endpoints
Sun, 03/20/22 - 10:59 pm
Sanofi
API
spinoffs
Paris
EuroAPI
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »